Legend Biotech Corp is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LEGN is expected to report earnings to fall 98.12% to 0 cents per share on November 17
Q3'26
Est.
$0.00
Q2'26
Beat
by $0.09
Q1'26
Missed
by $0.16
Q4'25
Est.
$0.01
Q3'25
Missed
by $0.07
The last earnings report on August 11 showed earnings per share of 15 cents, beating the estimate of 7 cents. With 875.86K shares outstanding, the current market capitalization sits at 3.62B.